Related references
Note: Only part of the references are listed.Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)
Alessandro Giollo et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India
Latika Gupta et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
Philippe Guilpain et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
What is the true incidence of COVID-19 in patients with rheumatic diseases?
Ennio Giulio Favalli et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Absence of Severe Complications From SARS-CoV-2 Infection in Children With Rheumatic Diseases Treated With Biologic Drugs
Giovanni Filocamo et al.
JOURNAL OF RHEUMATOLOGY (2021)
A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2
Seza Ozen et al.
JOURNAL OF RHEUMATOLOGY (2020)
Long-term Immunogenicity of Measles Vaccine: An Italian Retrospective Cohort Study
Francesco Paolo Bianchi et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Use of glucocorticoids in the critical care setting: Science and clinical evidence
Edward D. Chan et al.
PHARMACOLOGY & THERAPEUTICS (2020)
JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis
Elisabetta Miserocchi et al.
CLINICAL RHEUMATOLOGY (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Hussin A. Rothan et al.
JOURNAL OF AUTOIMMUNITY (2020)
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option
Tian-Tian Yao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Are children less susceptible to COVID-19?
Ping-Ing Lee et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
Huijun Chen et al.
LANCET (2020)
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Jasper Fuk-Woo Chan et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
Yajing Fu et al.
VIROLOGICA SINICA (2020)
Why is COVID-19 so mild in children?
Petter Brodin
ACTA PAEDIATRICA (2020)
COVID-19 Autopsies, Oklahoma, USA
Lisa M. Barton et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome
Marie-Helene Odievre et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey
Alessandro Tomelleri et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
Pierre-Marie Duret et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19
Haralampos M. Moutsopoulos
ANNALS OF THE RHEUMATIC DISEASES (2020)
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
Maximilian F. Konig et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Sara Monti et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
Carina Mihai et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
Paola Toniati et al.
AUTOIMMUNITY REVIEWS (2020)
SARS-CoV-2 infection among patients with systemic autoimmune diseases
Giacomo Emmi et al.
AUTOIMMUNITY REVIEWS (2020)
How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
Piercarlo Sarzi-Puttini et al.
AUTOIMMUNITY REVIEWS (2020)
Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
Omer Gendelman et al.
AUTOIMMUNITY REVIEWS (2020)
Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Bin Zhang et al.
CHEST (2020)
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection
Moussa Saleh et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)
COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
Yuanyuan Han et al.
CLINICAL IMMUNOLOGY (2020)
COVID-19-Considerations for the paediatric rheumatologist
Christian M. Hedrich
CLINICAL IMMUNOLOGY (2020)
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
Wen Zhang et al.
CLINICAL IMMUNOLOGY (2020)
Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
Durga Prasanna Misra et al.
CLINICAL RHEUMATOLOGY (2020)
Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration
Giovanni Damiani et al.
DERMATOLOGIC THERAPY (2020)
Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study
Ming-Ju Tsai et al.
ANNALS OF INTENSIVE CARE (2020)
Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
Thomas Menter et al.
HISTOPATHOLOGY (2020)
Measles Immunization: Worth Considering Containment Strategy for SARS-CoV-2 Global Outbreak
Varnit S. Hanker
INDIAN PEDIATRICS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19)
Sanket Shah et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China
Bo XU et al.
JOURNAL OF INFECTION (2020)
Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs
Jehun Song et al.
RHEUMATOLOGY INTERNATIONAL (2020)
Pandemic brings mass vaccinations to a halt
Leslie Roberts
SCIENCE (2020)
Tocilizumab for the treatment of severe coronavirus disease 2019
Rand Alattar et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Treatment with convalescent plasma for COVID-19 patients in Wuhan, China
Mingxiang Ye et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
COVID-19 epidemic: Disease characteristics in children
Jiatong She et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Capturing Patient-Reported Outcomes During the COVID-19 Pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey
Emily Sirotich et al.
ARTHRITIS CARE & RESEARCH (2020)
Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis
Ennio Giulio Favalli et al.
JOURNAL OF RHEUMATOLOGY (2020)
The Rheumatologist's Role in COVID-19
Randy Q. Cron et al.
JOURNAL OF RHEUMATOLOGY (2020)
Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic
Rosie Scuccimarri et al.
JOURNAL OF RHEUMATOLOGY (2020)
Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy
Stefania Costi et al.
PEDIATRIC DRUGS (2020)
Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak
Diego Fernandez-Nieto et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Alfonso J. Rodriguez-Morales et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
Fatih Haslak et al.
BALKAN MEDICAL JOURNAL (2020)
Addressing the Question of Dermatologic Manifestations of SARS-CoV-2 Infection in the Lower Extremities: A Closer Look at the Available Data and its Implications
Rami Basatneh et al.
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION (2020)
Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
Michael Day
BMJ-BRITISH MEDICAL JOURNAL (2020)
Non-steroidal anti-inflammatory drugs and covid-19
Paul Little
BMJ-BRITISH MEDICAL JOURNAL (2020)
Vascular skin symptoms in COVID-19: a French observational study
J. D. Bouaziz et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Hyperinflammatory shock in children during COVID-19 pandemic
Shelley Riphagen et al.
LANCET (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Baricitinib for COVID-19: a suitable treatment?
Ennio G. Favalli et al.
LANCET INFECTIOUS DISEASES (2020)
COVID-19 and smoking: A systematic review of the evidence
Constantine I. Vardavas et al.
TOBACCO INDUCED DISEASES (2020)
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
Lorenzo D'Antiga
LIVER TRANSPLANTATION (2020)
On the Alert for Cytokine Storm: Immunopathology in COVID-19
Lauren A. Henderson et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Lei Fang et al.
LANCET RESPIRATORY MEDICINE (2020)
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
T. Klopfenstein et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019-COVID-NET, 14 States, March 1-30, 2020
Shikha Garg et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 Infection in Children
Xiaoxia Lu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Yan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
Thomas J. Oxley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country
Francesco Licciardi et al.
PEDIATRIC RHEUMATOLOGY (2020)
Epidemiology of COVID-19 Among Children in China
Yuanyuan Dong et al.
PEDIATRICS (2020)
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
Amr H. Sawalha et al.
CLINICAL IMMUNOLOGY (2020)
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
Saeed K. Alzghari et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
The immune system of children: the key to understanding SARS-CoV-2 susceptibility?
Rita Carsetti et al.
LANCET CHILD & ADOLESCENT HEALTH (2020)
The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19
Qing Ye et al.
JOURNAL OF INFECTION (2020)
Viral dynamics in mild and severe cases of COVID-19
Yang Liu et al.
LANCET INFECTIOUS DISEASES (2020)
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
Mark P. Lythgoe et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
Alexis Mathian et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Perspectives of Immune Therapy in Coronavirus Disease 2019
Armen Yuri Gasparyan et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis
Khalid M. Dousa et al.
IDCASES (2020)
A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia
Yin Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Use of Convalescent Plasma Therapy in Two COVID-19 Patients With Acute Respiratory Distress Syndrome in Korea
Jin Young Ahn et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
Josef S. Smolen et al.
JOURNAL OF RHEUMATOLOGY (2019)
Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
I-Yin Chen et al.
FRONTIERS IN MICROBIOLOGY (2019)
Non-specific effects of BCG vaccine on viral infections
S. J. C. F. M. Moorlag et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
NLRP3/ASC/Caspase-1 axis and serine protease activity are involved in neutrophil IL-1β processing during Streptococcus pneumoniae infection
Tingjuan Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients
Guillaume Voiriot et al.
JOURNAL OF CLINICAL MEDICINE (2019)
A clinical score to guide in decision making for monogenic type I IFNopathies
Hafize Emine Sönmez et al.
PEDIATRIC RESEARCH (2019)
Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN- as biomarkers for early recognition
Yandie Li et al.
PEDIATRIC RHEUMATOLOGY (2019)
Glucocorticoid treatment in juvenile idiopathic arthritis
Ezgi Deniz Batu
RHEUMATOLOGY INTERNATIONAL (2019)
Virus-virus interactions impact the population dynamics of influenza and the common cold
Sema Nickbakhsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes
Chong-Shan Shi et al.
CELL DEATH DISCOVERY (2019)
Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review
Fabiola Atzeni et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity
Rob J. W. Arts et al.
CELL HOST & MICROBE (2018)
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Gina A. Montealegre Sanchez et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Antimicrobials and QT prolongation
Jay W. Mason
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management
Seza Ozen et al.
FRONTIERS IN IMMUNOLOGY (2017)
Periodic fever syndromes
Helen J. Lachmann
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2017)
The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome
Lawton K. Chung et al.
CELL HOST & MICROBE (2016)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study
Muriel Le Bourgeois et al.
JOURNAL OF PEDIATRICS (2016)
VIRAL INFECTION VIRAL INFECTION Changing sides to get in
Andrea Du Toit
NATURE REVIEWS MICROBIOLOGY (2016)
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
Michael F. Marmor et al.
OPHTHALMOLOGY (2016)
Trained immunity: A program of innate immune memory in health and disease
Mihai G. Netea et al.
SCIENCE (2016)
Severe Inflammation Following Vaccination Against Streptococcus pneumoniae in Patients With Cryopyrin-Associated Periodic Syndromes
Ulrich A. Walker et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine
John P. O'Laughlin et al.
CASE REPORTS IN CARDIOLOGY (2016)
Clinical features and correct diagnosis of macrophage activation syndrome
Randy Q. Cron et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
Macrophage Activation Syndrome
Angelo Ravelli et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)
A Case Series of Adenosine Deaminase 2-deficient Patients Emphasizing Treatment and Genotype-phenotype Correlations
Ezgi Deniz Batu et al.
JOURNAL OF RHEUMATOLOGY (2015)
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
Scott W. Canna et al.
NATURE GENETICS (2014)
Paediatric-onset systemic lupus erythematosus
Clara Malattia et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2013)
Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies
A. Danza et al.
LUPUS (2013)
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
Johanneke Kleinnijenhuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis
Karen Au et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
Armen Yuri Gasparyan et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
Sebastiaan J. Vastert et al.
RHEUMATOLOGY (2010)
Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates
Saskia L. Smits et al.
PLOS PATHOGENS (2010)
Interferons and viral infections
Volker Fensterl et al.
BIOFACTORS (2009)
CD4 T-Cell-Mediated Heterologous Immunity between Mycobacteria and Poxviruses
Keisha S. Mathurin et al.
JOURNAL OF VIROLOGY (2009)
Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Infection
Barry Rockx et al.
JOURNAL OF VIROLOGY (2009)
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome
Mark J. Cameron et al.
JOURNAL OF VIROLOGY (2007)
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan-Inge Henter et al.
PEDIATRIC BLOOD & CANCER (2007)
Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong
Loretta Yin-Chun Yam et al.
JOURNAL OF INFECTION (2007)
The spleen as a target in severe acute respiratory syndrome
Jun Zhan et al.
FASEB JOURNAL (2006)
Treatment of severe acute respiratory syndrome with glucosteroids - The Guangzhou experience
Rong-chang Chen et al.
CHEST (2006)
The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study
TW Auyeung et al.
JOURNAL OF INFECTION (2005)
High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome
JC Ho et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen
RE Berg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Bystander activation of CD8+ T cells contributes to the rapid production of IFN-γ in response to bacterial pathogens
G Lertmemongkolchai et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
